The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model.
about
Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled TrialsA systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problemsClinical relevance of nalmefene versus placebo in alcohol treatment: reduction in mortality riskRisk of All-Cause Mortality in Alcohol-Dependent Individuals: A Systematic Literature Review and Meta-Analysis.Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers.A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence.A Trial-Based Predictive Microsimulation Assessing the Public Health Benefits of Nalmefene and Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol Dependence.The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective.The Cost-Effectiveness of the Integration of Nalmefene within the UK Healthcare System Treatment Pathway for Alcohol Dependence.[Trends in pharmaceutical care for men].Evaluation in alcohol use disorders - insights from the nalmefene experienceThe cost-effectiveness of therapies to treat alcohol use disorders.Health-related quality of life in alcohol dependence: Similar cross-cultural impact beyond specific drinking habits.Nalmefene Prevents Alcohol-Induced Neuroinflammation and Alcohol Drinking Preference in Adolescent Female Mice: Role of TLR4.
P2860
Q26773290-395A1B88-E4DA-4B78-A1DA-04F44C135FA6Q28072735-8ED919B2-8E11-432C-9409-0F5AD8780958Q36216268-4E1AE21E-653C-4AF7-A45D-A718BF1F7E1FQ36251944-B4F25ECA-0D35-4BC3-AA2B-5936E2029DF3Q37384923-0F267D0D-1DFD-4EB6-BBC5-B1D331B28FF6Q39548027-FCFB2B80-EEBD-4F66-A348-0444BA127F72Q39694693-1E9C6BB4-78D8-4263-826C-69C5C13C91F4Q39995318-3F1B2A3E-2BDB-4959-8980-737D79F877D5Q40042538-5A467C14-4C05-46AF-ACA0-EBFCDC30F60CQ40678644-0BC0FDF4-0382-4DDD-AE08-2C4E299B39F0Q42348636-F7D4943C-C2CE-4904-BA6B-71F01490179FQ47599832-66CB5F43-197E-45E1-9C64-6B4E91897A83Q47647572-86EADCBC-E1DE-4B64-BD9A-29AD8186B835Q47767037-179A5EFA-F551-4147-86FA-4703C36B7631
P2860
The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The cost-effectiveness and pub ...... g risk levels: a Markov model.
@ast
The cost-effectiveness and pub ...... g risk levels: a Markov model.
@en
The cost-effectiveness and pub ...... g risk levels: a Markov model.
@nl
type
label
The cost-effectiveness and pub ...... g risk levels: a Markov model.
@ast
The cost-effectiveness and pub ...... g risk levels: a Markov model.
@en
The cost-effectiveness and pub ...... g risk levels: a Markov model.
@nl
prefLabel
The cost-effectiveness and pub ...... g risk levels: a Markov model.
@ast
The cost-effectiveness and pub ...... g risk levels: a Markov model.
@en
The cost-effectiveness and pub ...... g risk levels: a Markov model.
@nl
P2093
P2860
P1433
P1476
The cost-effectiveness and pub ...... g risk levels: a Markov model.
@en
P2093
Carolina Barbosa
Chris Knight
Clément François
Jean-Bernard Daeppen
Mondher Toumi
Nora Rahhali
Philippe Laramée
Thor-Henrik Brodtkorb
P2860
P304
P356
10.1136/BMJOPEN-2014-005376
P50
P577
2014-09-16T00:00:00Z